Projects

RNDr. Jana Klimentová, PhD.

International

Finished
  • Effects of antioxidants on metabolic syndrome: reactive oxygen species/nitric oxide balance
    Program: Inter-institute agreement
    Duration: 1. 1. 2007 – 31. 12. 2015
  • Different models of experimental hypertension and their vasoactive systems
    Program: Inter-institute agreement
    Duration: 1. 1. 2005 – 31. 12. 2009

National

Current
  • Effects of mesenchymal stem cells and HMGB1 inhibitor on cardiovascular system after experimentally induced myocardial infarction in hypertension and diabetes mellitus
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
Finished
  • Comparison of antidepressant effects of natural psychoplastogen and an mTOR activator in animal model of depression
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • The effect of aging and hypertension on experimental myocardial infarction
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • The effect of STAT1 and ISG15 inhibitors on biochemical and morphological parameters in experimental myocardial infarction
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • Participation of HMGB1 in experimental myocardial infarction: cardioprotection vs. cardiac depression
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • The effect of the lifestyle-related risk factors on the adaptive processes in the ischemic myocardium
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Modulatory effect of lifestyle-related risk factors on the mechanisms of subcellular adaptation to myocardial ischemia
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • The role of nuclear factor kappa B in experimental hypertension
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Effects of mesenchymal stem cells and HMGB1 inhibitor on cardiovascular system after experimentally induced myocardial infarction in hypertension and diabetes mellitus
    Program: SRDA
    Duration: 0. 0. 0000 – 0. 0. 0000
Employees